Q2 2022 Holdings
Filed 2022-08-15 | 71 holdings | $423.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $146.2M | 385,818 | 34.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $71.6M | 1,849,887 | 16.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $55.8M | 2,070,288 | 13.2% |
| Centene Corp del(CNC) | COM | 15135B101 | $55.1M | 651,447 | 13.0% |
| Absci Corporation(ABSI) | COM | 00091E109 | $26.7M | 8,031,094 | 6.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $24.9M | 300,000 | 5.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $13.2M | 3,503,190 | 3.1% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $8.9M | 1,306,339 | 2.1% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $6.3M | 1,920,960 | 1.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.2M | 766,797 | 1.5% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $4.8M | 567,800 | 1.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $738.0K | 696,377 | 0.2% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $583.0K | 266,365 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $321.1K | 12,957,222 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $238.0K | 22,158,891 | 0.1% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $151.1K | 854,013 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $124.7K | 1,898,545 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $101.4K | 1,623,762 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $72.8K | 913,319 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $66.7K | 5,186,348 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $63.7K | 3,645,309 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $60.1K | 3,334,355 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $59.7K | 7,512,029 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $51.3K | 2,607,130 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $49.9K | 1,639,344 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $49.5K | 2,004,663 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $48.6K | 6,242,756 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $41.1K | 9,141,045 | 0.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $40.5K | 83,987 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $39.8K | 19,808,234 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $38.5K | 25,192,751 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $38.1K | 3,006,684 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $38.1K | 2,720,996 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $35.5K | 4,521,825 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $28.0K | 1,833,547 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $26.3K | 1,993,268 | 0.0% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $25.9K | 14,380,327 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $24.6K | 3,069,001 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $23.8K | 1,954,419 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $22.8K | 5,619,914 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $22.7K | 1,383,619 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $20.3K | 3,835,818 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $20.0K | 736,175 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $18.8K | 1,430,917 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $18.7K | 3,403,926 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $17.8K | 405,517 | 0.0% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $17.6K | 1,115,825 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $16.8K | 6,952,760 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $15.0K | 1,587,285 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $14.9K | 817,832 | 0.0% |